JP2024523525A5 - - Google Patents

Info

Publication number
JP2024523525A5
JP2024523525A5 JP2023579274A JP2023579274A JP2024523525A5 JP 2024523525 A5 JP2024523525 A5 JP 2024523525A5 JP 2023579274 A JP2023579274 A JP 2023579274A JP 2023579274 A JP2023579274 A JP 2023579274A JP 2024523525 A5 JP2024523525 A5 JP 2024523525A5
Authority
JP
Japan
Application number
JP2023579274A
Other languages
Japanese (ja)
Other versions
JP2024523525A (ja
JPWO2022268152A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/100685 external-priority patent/WO2022268152A1/zh
Publication of JP2024523525A publication Critical patent/JP2024523525A/ja
Publication of JP2024523525A5 publication Critical patent/JP2024523525A5/ja
Publication of JPWO2022268152A5 publication Critical patent/JPWO2022268152A5/ja
Pending legal-status Critical Current

Links

JP2023579274A 2021-06-24 2022-06-23 Glp-1受容体アゴニストならびにその組成物および使用 Pending JP2024523525A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110702643.0 2021-06-24
CN202110702643 2021-06-24
PCT/CN2022/100685 WO2022268152A1 (zh) 2021-06-24 2022-06-23 Glp-1受体激动剂及其组合物和用途

Publications (3)

Publication Number Publication Date
JP2024523525A JP2024523525A (ja) 2024-06-28
JP2024523525A5 true JP2024523525A5 (https=) 2025-06-27
JPWO2022268152A5 JPWO2022268152A5 (https=) 2025-06-27

Family

ID=84544137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579274A Pending JP2024523525A (ja) 2021-06-24 2022-06-23 Glp-1受容体アゴニストならびにその組成物および使用

Country Status (18)

Country Link
US (2) US11981666B2 (https=)
EP (1) EP4361145A4 (https=)
JP (1) JP2024523525A (https=)
KR (1) KR20240024910A (https=)
CN (2) CN117098758A (https=)
AU (1) AU2022300055A1 (https=)
CA (1) CA3219984A1 (https=)
CL (1) CL2023003794A1 (https=)
CO (1) CO2023017726A2 (https=)
CR (1) CR20230611A (https=)
DO (1) DOP2023000275A (https=)
EC (1) ECSP23095307A (https=)
IL (1) IL309235A (https=)
MX (1) MX2023014985A (https=)
PE (1) PE20241794A1 (https=)
TW (1) TW202317553A (https=)
WO (1) WO2022268152A1 (https=)
ZA (1) ZA202400786B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3157525A1 (en) 2019-10-25 2021-04-29 Gilead Sciences, Inc. Glp-1r modulating compounds
PH12023552860A1 (en) 2021-04-21 2024-05-20 Gilead Sciences Inc Carboxy-benzimidazole glp-1r modulating compounds
IL310377A (en) 2021-08-30 2024-03-01 Mindrank Ai Ltd Novel aryl ether substituted heterocyclic compound as glp1r agonist
KR20240068737A (ko) 2021-09-27 2024-05-17 테른스 파마슈티칼스, 인크. Glp-1r 효능제로서의 벤즈이미다졸 카복실산
AU2022375634A1 (en) 2021-10-25 2024-06-06 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
KR20240150488A (ko) 2022-02-23 2024-10-15 테른스 파마슈티칼스, 인크. Glp-1r 작용제로서의 화합물
US20260097037A1 (en) 2022-09-22 2026-04-09 Shionogi & Co., Ltd. Fused ring compound having glp-1 receptor agonist effect
CN120530106A (zh) * 2022-12-13 2025-08-22 杭州中美华东制药有限公司 Glp-1受体激动剂的新晶型和制备方法及其药物组合物和用途
TW202440556A (zh) * 2022-12-13 2024-10-16 中國大陸商杭州中美華東製藥有限公司 鹽型的glp-1受體激動劑、其晶型和製備方法及其藥物組合物和用途
CN118496200A (zh) * 2023-02-14 2024-08-16 成都康弘药业集团股份有限公司 吲唑啉酮类化合物及其制备方法和用途
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
TW202504600A (zh) 2023-07-04 2025-02-01 大陸商杭州中美華東製藥有限公司 Glp1r激動劑及其中間體的製備方法
TW202521533A (zh) 2023-09-14 2025-06-01 香港商歌禮製藥(中國)有限公司 Glp-1r 激動劑及其治療方法
US12291530B1 (en) 2023-11-24 2025-05-06 Ascletis Pharma (China) Co., Limited GLP-1R agonist and therapeutic method thereof
WO2025158275A1 (en) 2024-01-24 2025-07-31 Pfizer Inc. Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds
WO2025189141A1 (en) 2024-03-08 2025-09-12 Annapurna Bio, Inc. Methods for treating obesity and increasing weight loss
WO2025252098A1 (zh) * 2024-06-05 2025-12-11 杭州中美华东制药有限公司 Glp-1受体激动剂的口服药物组合物及其制备方法
KR20260032385A (ko) * 2024-08-28 2026-03-09 주식회사유한양행 Glp-1 수용체 효능제 활성을 가진 시에노이미다졸 화합물, 이의 제조 방법, 및 이들의 의약 용도
CN119837849B (zh) * 2025-02-10 2025-06-13 中国科学院北京基因组研究所(国家生物信息中心) 蜡菊素在制备缓解和治疗受试者细胞红系分化障碍的药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727983B2 (en) 2008-03-07 2010-06-01 Transtech Pharma, Inc. Oxadiazoanthracene compounds for the treatment of diabetes
JP5755217B2 (ja) 2009-03-30 2015-07-29 トランステック・ファーマ,エルエルシー 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法
US10723699B2 (en) 2015-11-04 2020-07-28 Hyundai Pharm Co., Ltd. Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
EP3555064B9 (en) 2016-12-16 2023-03-01 Pfizer Inc. Glp-1 receptor agonists and uses thereof
KR101910586B1 (ko) 2017-03-03 2018-10-23 한국화학연구원 헤테로아릴이 치환된 2-페닐이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 GLP-1 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물
CR20210341A (es) * 2018-11-22 2021-11-25 Qilu Regor Therapeutics Inc Agonistas de glp-ir y usos de los mismos
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
WO2021018023A1 (zh) * 2019-08-01 2021-02-04 济南泰达领创医药技术有限公司 小分子glp-1受体调节剂
CA3157525A1 (en) * 2019-10-25 2021-04-29 Gilead Sciences, Inc. Glp-1r modulating compounds
WO2021160127A1 (en) * 2020-02-13 2021-08-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2022068772A1 (zh) * 2020-09-29 2022-04-07 深圳信立泰药业股份有限公司 一种苯并咪唑类衍生物及其制备方法和医药用途
EP4247804A1 (en) * 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
WO2022225914A1 (en) * 2021-04-21 2022-10-27 Gilead Sciences, Inc. Carboxy-benzimidazole glp-1r modulating compounds

Similar Documents

Publication Publication Date Title
JP2024523525A5 (https=)
CL2025003898A1 (es) Estación de conformado de productos huecos de fibra moldeada con elemento expandible y sistema de depósito de fluido
CL2025003781A1 (es) Segmento de adsorción para unidad de captura directa de aire.
BR102023012440A2 (https=)
BR102023009641A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BY13165U (https=)
BY13161U (https=)
CN307046183S (https=)
CN307045798S (https=)
CN307045630S (https=)
CN307044249S (https=)
CN307047567S (https=)
CN307048097S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13172U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
CN307048360S (https=)
BY13174U (https=)